Mission Bay Capital — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Wildtypewildtypefoods.comFeb 2018

Wildtype grows salmon directly from fish cells using cellular agriculture, allowing production of seafood without wild-caught or farmed fish.

BiotechClimate TechFoodTechSan Francisco, US

Justin Kolbeck(Founder)inArye Elfenbein(Founder)inJustin Kolbeck Arye Elfenbein(Founder)

BoardJohn Melas-Kyriazi(Director)

Co-investorsBay Bridge Ventures Climate CRV (Charles River Ventures)Maven Ventures Mission Biocapital Redefine Ventures Llc Root Ventures Manager, Llc +20 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ViewPoint Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.